Serial point-prevalence studies to investigate hospital antimicrobial prescribing

Journal of Pharmacy Practice and Research

Volumn 37, Issue 3, 2007, Pages 190-193

  Ho, Lisa ^a   Melvani, Sharmila ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; FLUCLOXACILLIN; GENTAMICIN; GLYCOPEPTIDE; MACROLIDE; MEROPENEM; NITROIMIDAZOLE; NITROIMIDAZOLE DERIVATIVE; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLONE DERIVATIVE; ROXITHROMYCIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG APPROVAL; DRUG INDICATION; DRUG USE; FEMALE; FREQUENCY ANALYSIS; HUMAN; INFECTION; INFECTION PREVENTION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHARMACIST; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY; SEX RATIO; STANDARD; VOMITING;

EID: 35349019776     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2007.tb00741.x     Document Type: Article

References (24)

1. Philmon C, Smith T, Williamson S, Goodman E. Controlling use of antimicrobials in a community teaching hospital. Infect Control Hosp Epidemiol 2006; 27: 239-44.
2. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance. Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25: 584-99.
3. Lawton RM, Fridkon SK, Gaynes RP, McGowan JE. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2000; 21: 256-9.
4. World Health Organization. Global strategy for containment of antimicrobial resistance. Geneva: WHO; 2001. Available from 〈www.who.int/ emc/amrpdfs/WHO_Global_Strategy_English.pdf〉.
5. Centers for Disease Control and Prevention. A public health action plan to combat antibiotic resistance. Washington DC: CDC; 2000. Available from 〈www.cdc.gov/drugresistance/actionplan/html/index.htm〉.
6. Ministry of Food, Agriculture and Fisheries. The Copenhagen recommendations: report from the invitational European Union Conference on the microbial threat. Copenhagen: Ministry of Food, Agriculture and Fisheries. September 1998: 1-52. Available from 〈www.tour.info.fr/tours/pap/articles/ copen2.htm〉.
7. Commonwealth Department of Health and Aged Care. The use of antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. Canberra: Commonwealth Department of Health and Aged Care, and Commonwealth Department of Agriculture, Fisheries and Forestry-Australia; 1999.
8. World Health Organization. Collaborative centre for drug statistics methodology. Geneva: WHO; 2002. Available from 〈www.whocc.no/atcddd〉.
9. Grayson ML, Melvani S, Kirsa SW, Cheung S, Korman AM, Garrett MK, et al. Impact of an electronic antibiotic advice and approval system on antibiotic prescribing in an Australian teaching hospital. Med J Aust 2004; 180: 455-8.
10. Dean B, Lawson W, Jacklin A, Rogers T, Azasian B, Holmes A. The use of serial point-prevalence studies to investigate hospital anti-infective prescribing. Int J Pharm Pract 2002; 10: 121-5.
11. Cooke J, Kubin T, Morris J, Ribas J, Krämer I, Kämmerer I, et al. Intravenous and oral antimicrobials in respiratory tract infection: an international observational study of hospital practice. Pharm World Sci 2002; 24: 247-55.
12. Gilman J, Myatt M. EpiCalc 2000 (version 1.02) statistical software. Available from 〈www.brixtonhealth.com/epicalc.html〉. Accessed 21 June 2005.
13. Raz R, Hassin D, Kitzes D, Kitzes R, Miron D, Nadler A, et al. The use of systemic antibiotics in seven community hospitals in northern Israel. J Infect 1998; 37: 224-8.
14. Scheckler W, Bennett J. Antibiotic usage in seven community hospitals. JAMA 1970; 213: 264-7.
15. Gendel I, Zaher A, Braun E, Levy Y, Krivoy N. Antibiotic utilisation prevalence: prospective comparison between two medial departments in a tertiary care university hospital. Pharmacoepidemiol Drug Saf 2004; 13: 735-9.
16. Craig WA, Uman SJ, Shaw WR, Ramgopal V, Eagan LL, Leopold ET. Hospital use of antimicrobial drugs. Survey of 19 hospitals and results of antimicrobial control program. Ann Intern Med 1978; 89: 793-856.
17. Vlahovic-Palcevski V, Dumpis U, Gulbinovic J, Gulbinovic J, Struwe J, Palcevski G, et al. Benchmarking antimicrobial drug use at university hospitals in five European countries. Clin Microbiol Infect 2007; 13: 277-83.
18. Usluer G, Ozgunes I, Leblebicioglu H. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalised patients in Turkey. Ann Clin Microbiol Antimicrob 2005; 4: 16.
19. Seaton RA, Nathwani D, Burton P, McLaughlin C, MacKenzie AR, Dundas S, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilizing the Glasgow Antimicrobial Audit Tool (GAAT). Int J Antimicrob Agent 2007; 29: 693-9.
20. Hughes A, Ariffin N, Hua TL, Abdul Molok H, Hashim S, Sarijo J, et al. Prevalence of nosocomial infection and antibiotic use at a university medical centre in Malaysia. Infect Control Hosp Epidemiol 2005; 26: 100-4.
21. McLaughlin CM, Bodasing N, Boyter A, Fenelon C, Fox JG, Seaton RA. Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study. Q J Med 2005; 98: 745-52.
22. Porretta A, Giuliani L, Vegni FE, Larosa M, Privitera G. Prevalence and patterns of antibiotic prescribing in Italian hospitals. Infection 2003; 31 (suppl 2): 16-21.
23. Di Giammarino L, Bibl F, Bissig M, Bernasconi B, Cerny A, Bernasconi E. Evaluation of prescription practices of antibiotics in a medium-sized Swiss hospital. Swiss Med Wkly 2005; 135: 710-14.
24. Dollman CM, Cooper CM. Communicable diseases intelligence supplement on antimicrobial resistance in Australia. Commun Dis Intell 2003; 27 (suppl): S19-S27.